HR7218

The BOLD Infrastructure for Alzheimer's Reauthorization Act of 2024 (H.R. 7218) was signed into law by The President on December 11, 2024, becoming Public Law No. 118-142. The bill reauthorizes through FY2029 cooperative agreements with state, local, and tribal health departments, regional centers for awareness and research, and data collection on Alzheimer's disease and related dementias. The funding mechanism is an authorization of $33 million per fiscal year from 2025 through 2029, amending Section 398B(e) of the Public Health Service Act. This is an authorization, not an appropriation, meaning actual funding requires separate appropriations bills. The $33 million annual amount is small relative to the healthcare sector, and the programs primarily fund public health infrastructure rather than direct procurement from publicly traded companies. The bill had strong bipartisan support with 79 cosponsors and passed both chambers unanimously. No publicly traded companies are directly named or clearly affected by this legislation, as the funding flows to government health departments and academic centers rather than for-profit entities. The policy area is Health, and the affected sector is Healthcare, but the financial impact on public markets is negligible.